Filling the need for trusted information on national health issues

Critics Question Effectiveness Of Medicines Patent Pool In Improving Access To Drugs

SciDev.Net: Merck’s HIV patent agreement ignites monopoly criticism
“Pharma giant Merck has become the latest drug company to share intellectual property rights with a U.N.-backed patent pool for HIV medicines, but critics have told SciDev.Net it is ‘a false solution to a real problem’…” (Kennedy, 3/16).